GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (FRA:PY30) » Definitions » Pre-Tax Income

Galderma Group AG (FRA:PY30) Pre-Tax Income : € Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Galderma Group AG's pretax income for the six months ended in Jun. 2024 was €72 Mil. Galderma Group AG does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in Jun. 2024. Galderma Group AG's pretax margin was 3.47%.

During the past 0 years, Galderma Group AG's highest Pretax Margin was 3.48%. The lowest was 0.00%. And the median was 0.00%.

Galderma Group AG Pre-Tax Income Historical Data

The historical data trend for Galderma Group AG's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Pre-Tax Income Chart

Galderma Group AG Annual Data
Trend
Pre-Tax Income

Galderma Group AG Semi-Annual Data
Jun23 Jun24
Pre-Tax Income -15.69 71.53

Competitive Comparison of Galderma Group AG's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's Pre-Tax Income falls into.


Galderma Group AG Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Galderma Group AG's Pretax Income for the fiscal year that ended in . 20 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=++++0
=0

Galderma Group AG's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=293.564+0+-226.676+3.716+0.92899999999997
=72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG  (FRA:PY30) Pre-Tax Income Explanation

Galderma Group AG's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=71.533/2058.664
=3.47%

During the past 0 years, Galderma Group AG's highest Pretax Margin was 3.48%. The lowest was 0.00%. And the median was 0.00%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (FRA:PY30) » Definitions » Pre-Tax Income
Comparable Companies
XSWX:SDZ XSWX:SFZN XSWX:PPGN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA NSE:DIVISLAB HKSE:03692 SZSE:000538 BOM:500087 ITCI VTRS TSE:4507 NBIX NSE:TORNTPHARM SHSE:688506
Traded in Other Exchanges
GALDY:USA GALDz:UK GALD:Switzerland
Address
Zahlerweg 10, Zug, CHE, 6300
Website
https://www.galderma.com
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines